Novel proteins associated with human dilated cardiomyopathy: selective reduction in α_1A-adrenergic receptors and increased desensitization proteins

References

• Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25–146
   PubMed Web of Science ®Google Scholar
• Corbett JM, Why HJ, Wheeler CH, et al. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1998;19:2031–42
   PubMed Web of Science ®Google Scholar
• Knecht M, Regitz-Zagrosek V, Pleissner KP, et al. Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J 1994;15:D37–44
   Google Scholar
• Pleissner KP, Regitz-Zagrosek V, Weise C, et al. Chamber-specific expression of human myocardial proteins detected by two-dimensional gel electrophoresis. Electrophoresis 1995;16:841–50
   Google Scholar
• De Weger RA, Schipper ME, Siera-de Koning E, et al. Proteomic profiling of the human failing heart after left ventricular assist device support. J Heart Lung Transplant 2011;30:497–506
   PubMedGoogle Scholar
• Roselló-Lletí E, Alonso J, Cortés R, et al. Cardiac protein changes in ischemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue. J Cell Mol Med 2012;16:2471–86
   Google Scholar
• Hamdani N, Linke WA. Alteration of the beta-adrenergic signaling pathway in human heart failure. Curr Pharm Biotechnol 2012 [Epub ahead of print].
   Google Scholar
• Steinberg SF. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 1999;85:1101–11
   PubMed Web of Science ®Google Scholar
• Bristow MR, Ginsburg R, Umans V, et al. β1- and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure. Circ Res 1986;59:297–309
   PubMed Web of Science ®Google Scholar
• Skomedal T, Borthne K, Aass H, et al. Comparison between α1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle. J Pharmacol Exp Ther 1997;280:721–9
   PubMedGoogle Scholar
• Jensen BC, Swigart PM, De Marco T, et al. α1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail 2009;2:654–63
   PubMed Web of Science ®Google Scholar
• Bristow MR, Minobe W, Rasmussen R, et al. α1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 1988;247:1039–45
   Google Scholar
• Bohm M, Diet F, Feiler G, et al. α-adrenoceptors and α-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 1988;12:357–64
   PubMedGoogle Scholar
• Vago T, Bevilacqua M, Norbiato G, et al. Identification of α1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ Res 1989;64:474–81
   PubMed Web of Science ®Google Scholar
• Limas CJ, Limas C, Goldenberg IF. Intracellular distribution of adrenoceptors in the failing human myocardium. Am Heart J 1989;117:1310–6
   Google Scholar
• Yang J, Moravec CS, Sussman MA, et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000;102:3046–52
   PubMed Web of Science ®Google Scholar
• Zuscik MJ, Chalothorn D, Hellard D, et al. Hypotension, autonomic failure and cardiac hypertrophy in transgenic mice over-expressing the α1B-adrenergic receptor. J Biol Chem 2001;276:13738–43
   PubMed Web of Science ®Google Scholar
• Hessel MH, Michielsen EC, Atsma DE, et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol 2008;85:90–5
   Google Scholar
• Abraham WT, Gilbert EM, Lowes BD, et al. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med 2002;8:750–60
   PubMedGoogle Scholar
• Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with β-blocking agents. N Engl J Med 2002;346:1357–65
   PubMed Web of Science ®Google Scholar
• Barrans JD, Allen PD, Stamatiou D, et al. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 2002;160:2035–43
   Google Scholar
• Hossein-Nia M, Baig K, Goldman JH, et al. Creatine kinase isoforms as circulating markers of deterioration in idiopathic dilated cardiomyopathy. Clin Cardiol 1997;20:55–60
   Google Scholar
• Li W, Rong R, Zhao S, et al. Proteomic analysis of metabolic, cytoskeletal and stress response proteins in human heart failure. J Cell Mol Med 2012;16:59–71
   PubMed Web of Science ®Google Scholar
• Iwaoka M, Obata JE, Abe M, et al. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail 2007;13:247–53
   Google Scholar
• Chen EP, Akhter SA, Bittner HB, et al. Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension. Ann Thorac Surg 1999;67:1053–8
   Google Scholar
• Salvi SS. α1-adrenergic hypothesis for pulmonary hypertension. Chest 1999;115:1708–19
   PubMed Web of Science ®Google Scholar
• León-Velarde F, Bourin MC, Germack R, et al. Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion. Am J Physiol Regul Integr Comp Physiol 2001;280:R274–81
   Google Scholar
• Williams RS, Lefkowitz RJ. Thyroid hormone regulation of α-adrenergic receptors: studies in rat myocardium. J Cardiovasc Pharmacol 1979;1:181–9
   Google Scholar
• Fox AW, Juberg EN, May JM, et al. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness. J Pharmacol Exp Ther 1985;235:715–23
   Google Scholar
• Nanchen D, Gussekloo J, PROSPER Group, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 2012;97:852–61
   PubMed Web of Science ®Google Scholar
• Triggiani V, Iacoviello M, Monzani F, et al. Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone. Endocr Metab Immune Disord Drug Targets 2012;12:86–94
   Google Scholar
• Grigore A, Poindexter B, Vaughn WK, et al. Alterations in α adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device. J Heart Lung Transplant 2005;24:609–13
   PubMedGoogle Scholar
• Schnee PM, Shah N, Bergheim M, et al. Location and density of α- and β-adrenoreceptor sub-types in myocardium after mechanical left ventricular unloading. J Heart Lung Transplant 2008;27:710–7
   Google Scholar
• Ogletree-Hughes ML, Stull LB, Sweet WE, et al. Mechanical unloading restores β-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001;104:881–6
   PubMed Web of Science ®Google Scholar
• Milting H, Scholz C, Arusoglu L, et al. Selective upregulation of β1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J Mol Cell Cardiol 2006;41:441–50
   Google Scholar
• Perez DM, Doze VA. Cardiac and neuroprotection regulated by 〈1-adrenergic receptor subtypes. J Recept Signal Transduct Res 2011;31:98–110
   PubMed Web of Science ®Google Scholar
• Jensen BC, O'Connell TD, Simpson PC. α1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol 2011;51:518–28
   PubMed Web of Science ®Google Scholar
• Chan T, Dash R, Simpson PC. An α1A-adrenergic receptor subtype agonist prevents cardiomyopathy without increasing blood pressure. (abstract) Circulation 2008;118:S533
   Google Scholar
• Donath S, Li P, Willenbockel C, et al. German Heart Failure Network. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 2006;113:1203–12
   PubMedGoogle Scholar
• Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953–8
   PubMed Web of Science ®Google Scholar
• Haase D, Lehmann MH, Körner MM, et al. Identification and validation of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy. Eur J Heart Fail 2002;4:23–31
   Google Scholar
• Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet 1996;13:63–9
   PubMed Web of Science ®Google Scholar
• Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of α-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001;33:723–32
   PubMed Web of Science ®Google Scholar
• Karibe A, Tobacman LS, Strand J, et al. Hypertrophic cardiomyopathy caused by a novel α-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 2001;103:65–71
   Google Scholar
• Von Arx P, Bantle S, Soldati T, Perriard JC. Dominant negative effect of cytoplasmic actin isoproteins on cardiomyocyte cytoarchitecture and function. J Cell Biol 1995;131:1759–73
   PubMed Web of Science ®Google Scholar
• Martin AF, Phillips RM, Kumar A, et al. Ca(2+) activation and tension cost in myofilaments from mouse hearts ectopically expressing enteric γ-actin. Am J Physiol Heart Circ Physiol 2002;283:H642–9
   Google Scholar
• Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990;322:100–10
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Ishibashi Y, Imanaka-Yoshida K, et al. Alterations in sarcoplasmic reticulum calcium-storing proteins in pressure-overload cardiac hypertrophy. Am J Physiol 1997;272:H168–75
   Google Scholar
• Lesnefsky EJ, Dauber IM, Horwitz LD. Myocardial sulfhydryl pool alterations occur during reperfusion after brief and prolonged myocardial ischemia in vivo. Circ Res 1991;68:605–13
   PubMed Web of Science ®Google Scholar
• Orii KE, Aoyama T, Wakui K, et al. Genomic and mutational analysis of the mitochondrial trifunctional protein beta-subunit (HADHB) gene in patients with trifunctional protein deficiency. Hum Mol Genet 1997;6:1215–24
   PubMed Web of Science ®Google Scholar
• O'Donnell JM, Fields AD, Sorokina N, Lewandowski ED. The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J Mol Cell Cardiol 2008;44:315–22
   PubMedGoogle Scholar
• Den Boer MEJ, Wanders RJA, Morris AA, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase: clinical presentation and follow up of 50 patients. Pediatrics 2002;109:99–104
   Google Scholar
• Olpin SE, Clark S, Andresen BS, et al. Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. J Inherit Metab Dis 2005;28:533–44
   Google Scholar
• Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1993;330:913–9
   Google Scholar
• Schaper J, Froede R, St Hein TA, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504–14
   PubMed Web of Science ®Google Scholar
• Mesaeli N, Nakamura K, Zvaritch E, et al. Calreticulin is essential for cardiac development. J Cell Biol 1999;144:857–68
   PubMedGoogle Scholar
• Papp S, Dziak E, Kabir G, et al. Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists. Am J Pathol 2010;176:1113–21
   Google Scholar
• Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003;426:574–9
   PubMed Web of Science ®Google Scholar
• Ungerer M, Bohm M, Elce JS, et al. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 1993;87:454–63
   PubMed Web of Science ®Google Scholar
• Vasudevan NT, Mohan ML, Gupta MK, et al. Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function. Mol Cell 2011;41:636–48
   Google Scholar
• Perrino C, Schroder JN, Lima B, et al. Dynamic regulation of phosphoinositide 3-kinase-gamma activity and β-adrenergic receptor trafficking in end-stage human heart failure. Circulation 2007;116:2571–9
   Google Scholar
• Shi T, Papay RS, Perez DM. α1A-AR differentially regulates STAT3 phosphorylation through PKCε and PKCδ in myocytes. J Receptors Signal Transduction 2012;32:76–86
   PubMed Web of Science ®Google Scholar
• Perez DM, Papay RS, Shi T. α1-Adrenergic receptor stimulates IL-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 MAPK and NF-κB. Mol Pharmacol 2009;76:144–52
   PubMedGoogle Scholar
• Huang Y, Wright CD, Merkwan CL, et al. An α1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 2007;115:763–72
   PubMed Web of Science ®Google Scholar
• Zhu WZ, Wang SQ, Chakir K, et al. Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 2003;111:617–25
   PubMed Web of Science ®Google Scholar
• Shizukuda Y, Buttrick PM. Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes. J Mol Cell Cardiol 2002;34:823–31
   PubMed Web of Science ®Google Scholar
• Communal C, Singh K, Sawyer DB, et al. Opposing effects of β1 and β2-adrenergic receptors on myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 1999;100:2210–12
   PubMed Web of Science ®Google Scholar